Our Blog Melanoma360

Featured image for “Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer Immunotherapy?”
01/27/2023

Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer Immunotherapy?

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory In January 2022, tebentafusp-tebn, also known under the more easily pronounceable…
Blog - Melanoma360
Melanoma Research
Featured image for “A Letter From Our Vice President | January 2023”
01/26/2023

A Letter From Our Vice President | January 2023

  Happy new year to you and your families! I hope that 2023 has started well for you. Before I…
Blog - Melanoma360
Melanoma Research
Featured image for “TISSUE IS THE ISSUE—2023 Update on AIM’s International Melanoma Tissue Bank Consortium”
01/26/2023

TISSUE IS THE ISSUE—2023 Update on AIM’s International Melanoma Tissue Bank Consortium

This article is an update of an article we published last year. AIM at Melanoma’s major research initiative—the International Melanoma…
Blog - Melanoma360
Melanoma Research
Featured image for “What Makes AIM’s IMTBC Even More Valuable”
01/26/2023

What Makes AIM’s IMTBC Even More Valuable

AIM at Melanoma’s major research project, the International Melanoma Tissue Bank Consortium (IMTBC), is the first collaborative fresh frozen primary…
Blog - Melanoma360
Melanoma Research
Featured image for “The Grieving Brain: The Science of Love and Loss”
01/11/2023

The Grieving Brain: The Science of Love and Loss

  Our guest Dr. Mary-Frances O’Connor is a renowned grief expert, author, neuroscientist, and an associate professor of psychology at…
Blog - Melanoma360
Podcast
Featured image for “AIM at Melanoma Earns a Four-Star Rating From Charity Navigator”
12/23/2022

AIM at Melanoma Earns a Four-Star Rating From Charity Navigator

December 21, 2022 (Richmond, California) AIM at Melanoma is proud to announce that its strong financial health and ongoing accountability…
Blog - Melanoma360
Philanthropy
Featured image for “The Future of Melanoma Treatment: 2023 and Beyond”
12/19/2022

The Future of Melanoma Treatment: 2023 and Beyond

Melissa Wilson, PA-C, MPAS from UPMC Hillman Cancer Center, and Vernon Sondak, MD, Chair, Department of Cutaneous Oncology, Moffitt Cancer…
Blog - Melanoma360
Podcast
Featured image for “Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update”
12/08/2022

Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update

December 07, 2022 07:00 ET | Source: Replimune Group Inc RP1 combined with nivolumab continues to demonstrate deep and durable responses in…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “How’s it Growing?”
11/16/2022

How’s it Growing?

AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
Blog - Melanoma360
Philanthropy
Featured image for “President’s Letter | November 2022”
11/16/2022

President’s Letter | November 2022

From the Desk of Samantha Guild November is the month to prioritize our gratitude, and I never tire of this…
Blog - Melanoma360
President's Letter
01/27/2023

Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer Immunotherapy?

By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory In January 2022, tebentafusp-tebn, also known under the more easily pronounceable…
Featured image for “Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer Immunotherapy?”
Blog - Melanoma360
 | 
Melanoma Research
01/26/2023

A Letter From Our Vice President | January 2023

  Happy new year to you and your families! I hope that 2023 has started well for you. Before I…
Featured image for “A Letter From Our Vice President | January 2023”
Blog - Melanoma360
 | 
Melanoma Research
01/26/2023

TISSUE IS THE ISSUE—2023 Update on AIM’s International Melanoma Tissue Bank Consortium

This article is an update of an article we published last year. AIM at Melanoma’s major research initiative—the International Melanoma…
Featured image for “TISSUE IS THE ISSUE—2023 Update on AIM’s International Melanoma Tissue Bank Consortium”
Blog - Melanoma360
 | 
Melanoma Research
01/26/2023

What Makes AIM’s IMTBC Even More Valuable

AIM at Melanoma’s major research project, the International Melanoma Tissue Bank Consortium (IMTBC), is the first collaborative fresh frozen primary…
Featured image for “What Makes AIM’s IMTBC Even More Valuable”
Blog - Melanoma360
 | 
Melanoma Research
01/11/2023

The Grieving Brain: The Science of Love and Loss

  Our guest Dr. Mary-Frances O’Connor is a renowned grief expert, author, neuroscientist, and an associate professor of psychology at…
Featured image for “The Grieving Brain: The Science of Love and Loss”
Blog - Melanoma360
 | 
Podcast
12/23/2022

AIM at Melanoma Earns a Four-Star Rating From Charity Navigator

December 21, 2022 (Richmond, California) AIM at Melanoma is proud to announce that its strong financial health and ongoing accountability…
Featured image for “AIM at Melanoma Earns a Four-Star Rating From Charity Navigator”
Blog - Melanoma360
 | 
Philanthropy
12/19/2022

The Future of Melanoma Treatment: 2023 and Beyond

Melissa Wilson, PA-C, MPAS from UPMC Hillman Cancer Center, and Vernon Sondak, MD, Chair, Department of Cutaneous Oncology, Moffitt Cancer…
Featured image for “The Future of Melanoma Treatment: 2023 and Beyond”
Blog - Melanoma360
 | 
Podcast
12/08/2022

Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update

December 07, 2022 07:00 ET | Source: Replimune Group Inc RP1 combined with nivolumab continues to demonstrate deep and durable responses in…
Featured image for “Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/16/2022

How’s it Growing?

AIM at Melanoma is honored to have been selected by the Matthew Hill Foundation to be a benefitting charity in…
Featured image for “How’s it Growing?”
Blog - Melanoma360
 | 
Philanthropy
11/16/2022

President’s Letter | November 2022

From the Desk of Samantha Guild November is the month to prioritize our gratitude, and I never tire of this…
Featured image for “President’s Letter | November 2022”
Blog - Melanoma360
 | 
President's Letter